Related Experiment Video
Updated: Aug 12, 2026

Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS
Published on: April 13, 2016
Chelator, metal ion and buffer studies for protein C separation
1College of Engineering, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA.
Insights
Protein C (PC) is crucial for preventing blood clots. A new method using immobilized metal affinity chromatography effectively separates PC from major milk proteins, enabling large-scale, low-cost production for treating PC deficiency.
Area of Science:
- Biochemistry
- Biotechnology
- Protein Purification
Background:
- Protein C (PC) is a vital anticoagulant in the human coagulation cascade.
- PC deficiency can lead to severe conditions like deep vein thrombosis (DVT).
- Transgenic animal milk is a potential source for therapeutic PC production.
Purpose of the Study:
- To develop an efficient and cost-effective method for separating Protein C from major milk components.
- To evaluate the efficacy of Immobilized Metal Affinity Chromatography (IMAC) for this separation.
Main Methods:
- Systematic screening of chelators, metal ions, and buffers for IMAC.
- Utilizing iminodiacetic acid (IDA) and Iron (Fe) for selective binding of PC.
- Analyzing the separation of PC from alpha-casein, beta-casein, kappa-casein, alpha-lactalbumin, and beta-lactoglobulin.
Main Results:
- The IDA-Fe IMAC system effectively separated Protein C from major milk proteins.
- Alpha-lactalbumin and beta-lactoglobulin were eluted in the starting buffer.
- Protein C was subsequently eluted, while casein proteins remained bound.
Conclusions:
- Immobilized Metal Affinity Chromatography with IDA-Fe is a promising technology for purifying Protein C from transgenic animal milk.
- This method facilitates large-scale, low-cost production of Protein C for therapeutic use in PC-deficient patients.
Abstract:
Protein C (PC) is the pivotal anticoagulant and antithrombotic in the human coagulation cascade. PC deficiency can result in major medical problems such as deep vein thrombosis (DVT), leading to tissue oxygen deprivation. PC treatment has no bleeding or skin necrosis problems because it circulates in the blood as a zymogen and is only activated when and where it is needed. One source of PC is transgenic animal milk. The major components in the milk, such as alpha-casein, beta-casein, kappa-casein, alpha-lactalbumin and beta-lactoglobulin, are proteins that must be separated from PC. Immobilized metal affinity chromatography (IMAC) is an inexpensive separation technology with relatively high specificity, and it has great potential for difficult protein separations. After systematic studies of different chelator, metal ion and buffers, the combination of iminodiacetic acid (IDA) and Fe was found to be effective to separate PC from major milk components. alpha-Lactalbumin and beta-lactoglobulin fell through the column in the starting buffer. PC was eluted. alpha-Casein, beta-casein, kappa-casein remained bound in the column after PC elution. This technology might be applied for PC separation from transgenic animal milk. It is very important for PC production in large quantities and at low cost to treat PC-deficient patients.
Related Concept Videos
Types Of Column Chromatography
Gel Filtration Chromatography
When the...
EDTA: Chemistry and Properties
Extraction: Advanced Methods
Ion-Exchange Chromatography
Capillary Electrophoresis: Applications
Capillary zone electrophoresis (CZE) separates ionic components based on their electrophoretic mobility. It has been used to separate proteins, amino acids,...

